SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 488 filers reported holding SEAGEN INC in Q4 2020. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,561,203 | +18.3% | 73,350 | +7.3% | 0.02% | +26.7% |
| Q2 2023 | $13,151,947 | -71.5% | 68,336 | -70.0% | 0.02% | -73.2% |
| Q1 2023 | $46,155,466 | +86.9% | 227,962 | +18.6% | 0.06% | +86.7% |
| Q4 2022 | $24,701,293 | -3.9% | 192,213 | +1.5% | 0.03% | -6.2% |
| Q3 2022 | $25,701,000 | -28.5% | 189,395 | -6.8% | 0.03% | -23.8% |
| Q2 2022 | $35,967,000 | -12.5% | 203,275 | -28.8% | 0.04% | +10.5% |
| Q1 2022 | $41,125,000 | -38.1% | 285,487 | -33.6% | 0.04% | -32.1% |
| Q4 2021 | $66,446,000 | +45.3% | 429,795 | +59.6% | 0.06% | +19.1% |
| Q3 2021 | $45,725,000 | +14.0% | 269,287 | +3.0% | 0.05% | +14.6% |
| Q2 2021 | $40,111,000 | +11.5% | 261,498 | +0.9% | 0.04% | +2.5% |
| Q1 2021 | $35,974,000 | -19.2% | 259,071 | +2.0% | 0.04% | -25.9% |
| Q4 2020 | $44,500,000 | – | 254,079 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |